Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IAS
2726
DELISTED
Integral Ad Science
IAS
| $6.84M | ﹤0.01% |
331,470
+226,470
| +216% | +$4.46M |
|
2727
Entravision Communication
EVC
$833M
| $6.79M | ﹤0.01% |
956,774
+24,104
| +3% | +$163K |
|
|
DFTX
2728
Definium Therapeutics
DFTX
$5.79B
| $6.79M | ﹤0.01% |
194,202
+13,396
| +7% | +$579K |
|
|
AUD
2729
DELISTED
Audacy, Inc.
AUD
| $6.77M | ﹤0.01% |
1,840,258
-66,805
| -4% | -$234K |
|
2730
Taysha Gene Therapies
TSHA
$1.84B
| $6.76M | ﹤0.01% |
363,016
+99,574
| +38% | +$1.89M |
|
|
ZIXI
2731
DELISTED
Zix Corporation
ZIXI
| $6.76M | ﹤0.01% |
955,655
+27,209
| +3% | +$196K |
|
2732
CNB Financial Corp
CCNE
$1.04B
| $6.75M | ﹤0.01% |
277,476
+4,143
| +2% | +$99.5K |
|
2733
Dyne Therapeutics
DYN
$4.75B
| $6.75M | ﹤0.01% |
415,524
+877
| +0.2% | +$15.5K |
|
|
FREE
2734
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $6.74M | ﹤0.01% |
583,141
+6,821
| +1% | +$85.6K |
|
2735
Bar Harbor Bankshares
BHB
$683M
| $6.72M | ﹤0.01% |
239,708
-1,812
| -0.8% | -$50.1K |
|
2736
UWM Holdings
UWMC
$2.55B
| $6.7M | ﹤0.01% |
964,740
+350,645
| +57% | +$2.61M |
|
2737
Marcus Corp
MCS
$925M
| $6.69M | ﹤0.01% |
383,630
-25,278
| -6% | -$412K |
|
|
MSP
2738
DELISTED
Datto Holding Corp.
MSP
| $6.69M | ﹤0.01% |
280,088
+5,382
| +2% | +$139K |
|
2739
Astronics
ATRO
$4.51B
| $6.68M | ﹤0.01% |
570,242
-23,976
| -4% | -$304K |
|
2740
Southern First Bancshares
SFST
$615M
| $6.68M | ﹤0.01% |
124,884
+480
| +0.4% | +$24.2K |
|
2741
Kopin
KOPN
$998M
| $6.67M | ﹤0.01% |
1,299,809
+31,812
| +3% | +$193K |
|
|
PRVB
2742
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $6.66M | ﹤0.01% |
1,040,106
+99,502
| +11% | +$639K |
|
2743
Seres Therapeutics
MCRB
$46.9M
| $6.65M | ﹤0.01% |
47,767
-7,549
| -14% | -$1.48M |
|
2744
Relmada Therapeutics
RLMD
$503M
| $6.65M | ﹤0.01% |
253,703
+9,371
| +4% | +$251K |
|
2745
Custom Truck One Source
CTOS
$2.34B
| $6.65M | ﹤0.01% |
712,564
+470,770
| +195% | +$3.96M |
|
2746
Identive
INVE
$63.9M
| $6.63M | ﹤0.01% |
352,122
+32,327
| +10% | +$550K |
|
2747
argenx
ARGX
$52.5B
| $6.63M | ﹤0.01% |
21,951
-2,281
| -9% | -$723K |
|
|
AFMD
2748
DELISTED
Affimed
AFMD
| $6.62M | ﹤0.01% |
107,097
+31
| +0% | +$2.04K |
|
|
CNBKA
2749
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $6.61M | ﹤0.01% |
57,356
+1,338
| +2% | +$153K |
|
2750
Arbutus Biopharma
ABUS
$914M
| $6.61M | ﹤0.01% |
1,540,431
+253,773
| +20% | +$846K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.